In a dramatic turn of events, LifeMD, Inc. finds itself embroiled in a class action lawsuit, as shareholders seek to recover losses incurred due to alleged securities fraud. The lawsuit targets the period between May 7, 2025, and August 5, 2025, during which LifeMD’s financial disclosures are claimed to have been misleading. At the heart of the allegations is the assertion that LifeMD, under the guise of a robust competitive position, failed to account for escalating customer acquisition costs within its RexMD segment. This oversight extended to the costs associated with promoting obesity treatments like Wegovy and Zepbound. Consequently, the company’s optimistic 2025 financial guidance is now under scrutiny, with claims that it lacked a reasonable foundation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
For those who have suffered financial losses during this period, there is an opportunity to seek recovery. Affected shareholders are encouraged to visit the provided link to understand their rights and explore the possibility of joining the lawsuit. Importantly, there is no cost or obligation to participate in this legal action.
The legal proceedings are spearheaded by Levi & Korsinsky LLP, a firm renowned for its prowess in securities litigation. With over two decades of experience and a formidable team, Levi & Korsinsky has consistently secured substantial settlements for shareholders, earning a spot among the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171